Longeveron/$LGVN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Longeveron
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Ticker
$LGVN
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
25
Website
Longeveron Metrics
BasicAdvanced
$24M
-
-$2.04
0.20
-
Price and volume
Market cap
$24M
Beta
0.2
52-week high
$2.24
52-week low
$1.14
Average daily volume
601K
Financial strength
Current ratio
5.608
Quick ratio
5.27
Long term debt to equity
3.87
Total debt to equity
7.547
Profitability
EBITDA (TTM)
-16.486
Gross margin (TTM)
82.25%
Net profit margin (TTM)
-760.72%
Operating margin (TTM)
-791.60%
Revenue per employee (TTM)
$90,000
Management effectiveness
Return on assets (TTM)
-72.08%
Return on equity (TTM)
-167.59%
Valuation
Price to revenue (TTM)
9.116
Price to book
1.41
Price to tangible book (TTM)
1.63
Price to free cash flow (TTM)
-1.224
Free cash flow yield (TTM)
-81.71%
Free cash flow per share (TTM)
-1.324
Growth
Revenue change (TTM)
127.51%
Earnings per share change (TTM)
-78.50%
3-year revenue growth (CAGR)
19.62%
3-year earnings per share growth (CAGR)
-38.60%
What the Analysts think about Longeveron
Majority rating from 2 analysts.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Longeveron stock?
Longeveron (LGVN) has a market cap of $24M as of August 01, 2025.
What is the P/E ratio for Longeveron stock?
The price to earnings (P/E) ratio for Longeveron (LGVN) stock is 0 as of August 01, 2025.
Does Longeveron stock pay dividends?
No, Longeveron (LGVN) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next Longeveron dividend payment date?
Longeveron (LGVN) stock does not pay dividends to its shareholders.
What is the beta indicator for Longeveron?
Longeveron (LGVN) has a beta rating of 0.2. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.